top of page

89bio to Participate in the Leerink Partners Global Biopharma Conference

SAN FRANCISCO, March 05, 2024 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Company’s Management will participate in a fireside chat at the Leerink Partners Global Biopharma Conference on Tuesday, March 12, 2024 at 1:40 PM EST and participate in one-on-one investor meetings. 89bio to Participate in the Leerink Partners Global Biopharma Conference

Aktuelle Beiträge

Alle ansehen

Comments


bottom of page